From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress

B Dewdney, MR Jenkins, SA Best, S Freytag… - … and Targeted Therapy, 2023 - nature.com
Glioblastoma, a rare, and highly lethal form of brain cancer, poses significant challenges in
terms of therapeutic resistance, and poor survival rates for both adult and paediatric patients …

Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: A systematic review

AO Akinyemi, KE Simpson, SF Oyelere, M Nur… - Molecular …, 2023 - Springer
Abstract Glucose-Regulated Protein 78 (GRP78) is a chaperone protein that is
predominantly expressed in the lumen of the endoplasmic reticulum. GRP78 plays a crucial …

ER chaperone GRP78/BiP translocates to the nucleus under stress and acts as a transcriptional regulator

Z Liu, G Liu, DP Ha, J Wang, M **ong… - Proceedings of the …, 2023 - pnas.org
Cancer cells are commonly subjected to endoplasmic reticulum (ER) stress. To gain survival
advantage, cancer cells exploit the adaptive aspects of the unfolded protein response such …

Cooperative CAR targeting to selectively eliminate AML and minimize escape

S Haubner, J Mansilla-Soto, S Nataraj, F Kogel… - Cancer Cell, 2023 - cell.com
Acute myeloid leukemia (AML) poses a singular challenge for chimeric antigen receptor
(CAR) therapy owing to its phenotypic heterogeneity and similarity to normal hematopoietic …

Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside

B Zhang, M Yang, W Zhang, N Liu, D Wang… - Cell Death & …, 2024 - nature.com
Immunotherapy has rapidly evolved in the past decades in the battle against cancer.
Chimeric antigen receptor (CAR)-engineered T cells have demonstrated significant success …

Applying a clinical lens to animal models of CAR-T cell therapies

BB Duncan, CE Dunbar, K Ishii - Molecular Therapy Methods & Clinical …, 2022 - cell.com
Chimeric antigen receptor (CAR)-T cells have emerged as a promising treatment modality
for various hematologic and solid malignancies over the past decade. Animal models …

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies

N Watanabe, F Mo, R Zheng, R Ma, VC Bray… - Molecular Therapy, 2023 - cell.com
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy

J He, Y Zhou, L Sun - Cell Communication and Signaling, 2024 - Springer
The accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER)
causes ER stress and activates the unfolded protein response (UPR). As an adaptive …

Biomarkers as targets for CAR-T/NK cell therapy in AML

R Shao, Z Li, H **n, S Jiang, Y Zhu, J Liu, R Huang… - Biomarker …, 2023 - Springer
The most common kind of acute leukemia in adults is acute myeloid leukemia (AML), which
is often treated with induction chemotherapy regimens followed by consolidation or …

Cell surface GRP78: a potential mechanism of therapeutic resistant tumors

R Amaresan, U Gopal - Cancer Cell International, 2023 - Springer
GRP78 is a protein that acts as a chaperone within the endoplasmic reticulum (ER) and has
multiple functions. It is induced by stress and abets cells from survival. Despite, multiple …